| Trial Identifier: | D4884C00001 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT02527434 |
| Start Date: | November 2015 |
| Primary Completion Date: | February 2018 |
| Study Completion Date: | March 2023 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Translation | |
| Dutch Translation | |
| Dutch Translation | |
| French Translation | |
| German Translation | |
| Korean Translation | |
| Polish Translation |
| Country | Location |
|---|---|
| BE | Brussels, BE, 1090 |
| BE | Charleroi, BE, 6000 |
| BE | Wilrijk, BE, 2610 |
| KR | Daejeon, KR, 35015 |
| KR | Seoul, KR, 03722 |
| KR | Seoul, KR, 03080 |
| KR | Seoul, KR, 135-710 |
| NL | Groningen, NL, 9713 GZ |
| NL | UTRECHT, NL, 3584 CX |
| PL | Gdańsk, PL, 80-214 |
| PL | Łódź, PL, 93-513 |
| US, CA | San Francisco, CA, US, 94158 |
| US, TN | Memphis, TN, US, 38120 |
| US, TX | Houston, TX, US, 77030 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company